Study Details
A Study evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients with Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Clinicaltrials.gov ID
Astellas Study ID
OSI-906-202
EudraCT ID
2009-010319-34
Condition
Ovarian Cancer, Advanced/Metastatic Cancer
Phase
Phase 1
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Aug 2009 - Aug 2014
Masking
None (Open Label)
Enrollment number
152
A Phase 1/2 Study evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients with Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients with Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Mater Adult Hospital
South Brisbane, Australia, 4101
University College Hospital
London, United Kingdom, WC1E 6BT
Sir Charles Gairdner Hospital
Perth, Australia, 6009
St. John of Gog Hospital, Subiaco
Subiaco, Australia, 6008
Mount Vernon Cancer Center
Northwood, United Kingdom, HA62RN
Border Medical Oncology
Wodonga, Australia, 3690
Clinical Caunty Hospital Mures
Mures, Romania, 540072
Department of Obstetrics and Gynecology, University of California, Irvine
Orange, United States, 92868
Princess Margaret Hospital
Toronto, Canada, M5G 2M9
Sity Clinical Oncology
St. Petersburg, Russian Federation, 198255
WestMead Hospital
WestMead, Australia, 2145
Instituto Europeo di Oncologia
Milan, Italy, 20141
Oddzial Radioterapii
Poznan, Poland, 61 866
University of Oklahoma Health Sciences Center
Oklahoma City, United States, 73104
Duke University Medical Center
Durham, United States, 27710
Ospedale San Giovanni
Bellinzona, Switzerland, CH-6500
Christie NHS Foundation Trust
Withington, United Kingdom, M20 4BX
State Institution Medical Radiology Scientific Center
Obninsk, Russian Federation, 249036
St. John of God Hospital, Bunbury
Bunbury, Australia, 6230
Ochsner Clinic Foundation
New Orleans, United States, 70121
Royal Marsden Hospital
London, United Kingdom, SW3 6JJ
Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie
Cluj Napoca, Romania, 400015
General University Hospital, Department of Obstetrics and Gynecology
Prague, Czech Republic, 212000
Klinika Onkologii AM w Poznaniu
Poznan, Poland, 61-878
Mayo Clinic
Scottsdale, United States, 85259
McGill University
Montreal, Canada, H3T 1E2
Central Clinical Hospital
Moscow, Russian Federation, 129128
Morristown Memorial Hospital
Morristown, United States, 07960
Royal Adelaide Hospital
North Terrace, Australia, 5000
Horizon Oncology Center
Lafayette, United States, 47906
Oncology IDI- IRCSS
Roma, Italy, 67100
Moscow City Oncology Hospital
Moscow, Russian Federation, 143423
University Hospital Hradec Kralove
Kralove, Czech Republic, 50005
Blumenthal Cancer Center - Main
Charlotte, United States, 28204
III Oddzial Onkologii Ginekologicznej
Lublin, Poland, 20-090
Drug Development Unit Royal Mardsen NHS Foundation Trust
Sutton, United Kingdom, SM2 5PT
Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala
Cluj Napoca, Romania, 400015
Launceston General Hospital
Launceston, Australia, 7250
Ospedale di Carpi, AUSL di Modena
Carpi, Italy, 91012
Churchill Hospital
Oxford, United Kingdom, OX37LI
Oncology Medical Centre SCM
Iasi, Romania, 700106
Frankston Hospital
Frankston, Australia, 3199
Juravinski Cancer Center
Hamilton, Canada, L8V 5C2
Universitaria di Bologna Policlinico
Bologna, Italy, 40138
The Christie NHS Foundation Trust
Manchester, United Kingdom, M20 4BX
University Hospital Ostrava
Ostrava- Poruba, Czech Republic, 70852